The present invention discloses the use of carbon monoxide releasing molecules in the preparation of an early drug for treating sepsis. The inventor after a large number of cell and animal experiments showed that the release of carbon monoxide molecules dissolved in the solvent of DMSO, then placed in the cells or organisms, can be sustained release of CO, so it can be used as an exogenous CO donor, and the use of LPS cells stimulated by inflammatory model and CLP septic mice sepsis model, early intervention experiment, found that CO releasing molecules can be used as drugs early suppression of sepsis. The carbon monoxide releasing molecule is used for inhibiting sepsis, and the concentration control is relatively easy and correct, and is convenient for long-term use. It can meet the needs of clinical application.
【技术实现步骤摘要】
【技术保护点】
一氧化碳释放分子CORM-2在制备早期治疗脓毒症药物中的应用。
【技术特征摘要】
【专利技术属性】
技术研发人员:孙炳伟,刘东明,陈曦,
申请(专利权)人:江苏大学附属医院,
类型:发明
国别省市:32[中国|江苏]
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。